Antiepileptic drugs and mood stability

被引:20
作者
Amann, Benedikit [1 ]
Grunze, Heinz [2 ]
Vieta, Eduard [3 ]
Trimble, Michael [4 ]
机构
[1] Hosp Benito Menni, Barcelona, Spain
[2] Univ Munich, Dept Psychiat, Munich, Germany
[3] Univ Barcelona, Hosp Clin Barcelona, Bipolar Disorder Programme, Barcelona, Spain
[4] UCL, Inst Neurol, London, England
关键词
antiepileptic drugs; bipolar disorder; carbamazepine; lamotrigine; mood stabilizer; seizures; valproate;
D O I
10.1177/155005940703800214
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This paper will discuss different definitions of the term "mood stabilizer" and highlight in detail the antiepileptic drugs carbamazepine, valproate and lamotrigine with respect to their relative strengths in stabilizing mood in bipolar patients. These drugs are heterogeneous in their mechanisms of action and in their efficacy to stabilize patients with epilepsy and the various mood states in bipolar disorder. Lamotrigine has obtained approval in several countries for the indication of preventing bipolar depressive episodes, which raises the question of differential efficacy of other antiepileptic drugs as mood stabilizers in the prevention of either depressive or hypo-/manic episodes. A Medline Search to 2006 was conducted for controlled acute and maintenance studies of the three scientifically and clinically most established antiepileptic drugs carbamazepine, valproate and lamotrigine. The medications discussed in this review only partly fulfill definitions of a mood stabilizer, and we suggest that future research should focus on combined treatment strategies.
引用
收藏
页码:116 / 123
页数:8
相关论文
共 61 条
  • [1] Neurochemical underpinnings in bipolar disorder and epilepsy
    Amann, B
    Grunze, H
    [J]. EPILEPSIA, 2005, 46 : 26 - 30
  • [2] [Anonymous], APA 2002 SYLL P SUMM
  • [3] BALLENGER JC, 1980, AM J PSYCHIAT, V137, P782
  • [4] BALLENGER JC, 1978, COMMUN PSYCHOPHARMAC, V2, P159
  • [5] Bowden Charles L, 2002, Expert Opin Pharmacother, V3, P1513, DOI 10.1517/14656566.3.10.1513
  • [6] A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder
    Bowden, CL
    Calabrese, JR
    McElroy, SL
    Gyulai, L
    Wassef, A
    Petty, F
    Pope, HG
    Chou, JCY
    Keck, PE
    Rhodes, LJ
    Swann, AC
    Hirschfeld, RMA
    Wozniak, PJ
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (05) : 481 - 489
  • [7] New concepts in mood stabilization: Evidence for the effectiveness of valproate and lamotrigine
    Bowden, CL
    [J]. NEUROPSYCHOPHARMACOLOGY, 1998, 19 (03) : 194 - 199
  • [8] EFFICACY OF DIVALPROEX VS LITHIUM AND PLACEBO IN THE TREATMENT OF MANIA
    BOWDEN, CL
    BRUGGER, AM
    SWANN, AC
    CALABRESE, JR
    JANICAK, PG
    PETTY, F
    DILSAVER, SC
    DAVIS, JM
    RUSH, AJ
    SMALL, JG
    GARZATREVINO, ES
    RISCH, SC
    GOODNICK, PJ
    MORRIS, DD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (12): : 918 - 924
  • [9] A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder
    Bowden, CL
    Calabrese, JR
    Sachs, G
    Yatham, LN
    Asghar, SA
    Hompland, M
    Montgomery, P
    Earl, N
    Smoot, TM
    DeVeaugh-Geiss, J
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (04) : 392 - 400
  • [10] CARBAMAZEPINE COMPARED TO HALOPERIDOL IN ACUTE MANIA
    BROWN, D
    SILVERSTONE, T
    COOKSON, J
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1989, 4 (03) : 229 - 238